Current and historical daily PE Ratio for Orchid Pharma Ltd (
) from 1997 to Jun 07 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Orchid Pharma stock (NSE:ORCHPHARMA) PE ratio as of Jun 07 2024 is 54.73.
More Details
Orchid Pharma Ltd (NSE:ORCHPHARMA) PE Ratio (TTM) Chart
Orchid Pharma Ltd (NSE:ORCHPHARMA) PE Ratio (TTM) Historical Data
View and export this data going back to 1997. Start your Free Trial
Total 1293
- 1
- 2
- 3
- 4
- 5
- 6
- 15
| Orchid Pharma PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
| 2024-06-07 | 55.8 | 2024-04-08 | 59.3 |
| 2024-06-06 | 55.8 | 2024-04-05 | 58.8 |
| 2024-06-05 | 52.4 | 2024-04-04 | 59.3 |
| 2024-06-04 | 50.3 | 2024-04-03 | 57.8 |
| 2024-06-03 | 52.3 | 2024-04-02 | 57.3 |
| 2024-05-31 | 52.6 | 2024-04-01 | 58.0 |
| 2024-05-30 | 52.8 | 2024-03-29 | 54.8 |
| 2024-05-29 | 53.9 | 2024-03-28 | 54.8 |
| 2024-05-28 | 54.0 | 2024-03-27 | 39.2 |
| 2024-05-27 | 53.7 | 2024-03-26 | 39.8 |
| 2024-05-24 | 53.9 | 2024-03-25 | 39.4 |
| 2024-05-23 | 57.5 | 2024-03-22 | 39.4 |
| 2024-05-22 | 56.5 | 2024-03-21 | 39.6 |
| 2024-05-21 | 57.4 | 2024-03-20 | 37.8 |
| 2024-05-20 | 57.3 | 2024-03-19 | 36.7 |
| 2024-05-18 | 56.4 | 2024-03-18 | 38.6 |
| 2024-05-17 | 57.3 | 2024-03-15 | 36.5 |
| 2024-05-16 | 56.7 | 2024-03-14 | 36.9 |
| 2024-05-15 | 57.6 | 2024-03-13 | 36.3 |
| 2024-05-14 | 53.2 | 2024-03-12 | 37.3 |
| 2024-05-13 | 53.2 | 2024-03-11 | 38.7 |
| 2024-05-10 | 54.3 | 2024-03-08 | 40.2 |
| 2024-05-09 | 53.5 | 2024-03-07 | 40.2 |
| 2024-05-08 | 54.1 | 2024-03-06 | 40.5 |
| 2024-05-07 | 52.2 | 2024-03-05 | 42.2 |
| 2024-05-06 | 53.5 | 2024-03-04 | 44.4 |
| 2024-05-03 | 54.8 | 2024-03-01 | 43.8 |
| 2024-05-02 | 55.6 | 2024-02-29 | 44.1 |
| 2024-05-01 | 56.6 | 2024-02-28 | 45.3 |
| 2024-04-30 | 56.6 | 2024-02-27 | 45.6 |
| 2024-04-29 | 57.0 | 2024-02-26 | 46.1 |
| 2024-04-26 | 56.9 | 2024-02-23 | 45.4 |
| 2024-04-25 | 57.3 | 2024-02-22 | 42.8 |
| 2024-04-24 | 55.9 | 2024-02-21 | 43.6 |
| 2024-04-23 | 55.4 | 2024-02-20 | 41.2 |
| 2024-04-22 | 55.2 | 2024-02-19 | 41.3 |
| 2024-04-19 | 55.8 | 2024-02-16 | 40.7 |
| 2024-04-18 | 56.2 | 2024-02-15 | 41.6 |
| 2024-04-17 | 57.7 | 2024-02-14 | 41.7 |
| 2024-04-16 | 57.7 | 2024-02-13 | 40.7 |
| 2024-04-15 | 57.6 | 2024-02-12 | 39.0 |
| 2024-04-12 | 57.1 | 2024-02-09 | 37.8 |
| 2024-04-11 | 60.8 | 2024-02-08 | 32.8 |
| 2024-04-10 | 60.8 | 2024-02-07 | 31.8 |
| 2024-04-09 | 61.9 | 2024-02-06 | 30.8 |
Orchid Pharma Ltd (NSE:ORCHPHARMA) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
Orchid Pharma Ltd
NAICS : 325412
ISIN : INE191A01027
Compare
Compare
Traded in other countries / regions
ORCHPHARMA.IndiaORCHP.Luxembourg IPO Date
1997-07-02Description
Orchid Pharma Ltd is involved in the development, manufacturing, and marketing of diverse bulk actives, formulations, and nutraceuticals. The company operates in one business segment which is Pharmaceutical Products. The company produces various products for cardiovascular, anti-diabetic, neuropsychiatry, veterinary, non-antibiotics, and cephalosporins. The products are grouped under formulations and active pharmaceutical ingredients. The company operates its business throughout the Indian region.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers